Burimamide was first developed by scientists at Smith, Kline & French (SK&F; now GlaxoSmithKline) in their intent to develop a histamine antagonist for the treatment of peptic ulcers. The discovery of buriamide ultimately led to the development of cimetidine (Tagamet). ...
Found on http://en.wikipedia.org/wiki/Burimamide


<chemical> An antagonist of histamine that appears to block both h2 and h3 histamine receptors. It has been used in the treatment of ulcers. ... Pharmacological action: anti-ulcer agents, histamine h2 antagonists. ... Chemical name: Thiourea, N-(4-(1H-imidazol-4-yl)butyl)-N'-methyl- ... (12 Dec 1998) ...
Found on http://www.encyclo.co.uk/local/20973
No exact match found